Modern biologics achieve complete skin clearance [100% improvement in psoriasis area and severity index (PASI 100)] in 30–45% of psoriasis patients. Cumulative benefit considering rapidity, frequency and sustainability of response… Click to show full abstract
Modern biologics achieve complete skin clearance [100% improvement in psoriasis area and severity index (PASI 100)] in 30–45% of psoriasis patients. Cumulative benefit considering rapidity, frequency and sustainability of response has not been thoroughly investigated.
               
Click one of the above tabs to view related content.